Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
TRex Bio, Inc. prices its initial public offering at $14.00 per share, raising approximately $116.7 million. The IPO is expected to close on October 13, 2026.
Amount Raised
$117 Million
Round Type
Post-IPO Equity
South San FranciscoBiotechnologyHealth CareTherapeuticsInvestors
Description
TRex Bio, Inc. has announced the pricing of its initial public offering, offering 8,333,334 shares at $14.00 per share. The IPO is expected to raise approximately $116.7 million before expenses. Shares are expected to trade on the Nasdaq under the ticker symbol 'TRXB'
Fundz sees it the moment TRex Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
TRex Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.